Clinical Trial Update: Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide [Phase 1]

View source ↗

Summary

Phase I dose-escalation study of azacitidine in combination with temozolomide in soft tissue sarcoma and mesothelioma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma
• Soft Tissue Sarcoma

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Columbia University | Conditions: Soft Tissue Sarcoma, Mesothelioma | Phase 1 | Status: COMPLETED | Results posted: 2025-06-05